Simultaneous bilateral shoulder arthroplasty: a case series.

BACKGROUND: Staged bilateral shoulder arthroplasty procedures have been shown to have good functional outcomes. The next step is to explore the option of simultaneous bilateral shoulder arthroplasty (SBSA). We report on the first case series of SBSA in the United States. The purpose of this study was to examine the safety and postoperative complication profile of SBSA and provide a technique reference for surgeons considering performing or investigating this procedure. METHODS: We conducted a retrospective record review of all the SBSA procedures performed by the senior author between 2007 and 2020. Patient demographic characteristics, surgical information, and postoperative data were collected. Data were compiled, and means, standard deviations, and ranges were calculated. Any readmissions or postoperative complications requiring revision were noted. A cohort of patients matched for age, sex, and body mass index with staged (sequential) bilateral total shoulder arthroplasty was analyzed for comparison. RESULTS: Thirteen patients were identified in the simultaneous group (SBSA). The mean age was 64 ± 15 years, with 9 women (69%) and 4 men (31%); the mean body mass index was 29.1 ± 7.5. The mean American Society of Anesthesiologists score was 2.55 ± 0.7, average blood loss was 364 ± 170 mL (range, 50-600 mL), 5 of 13 patients (38%) underwent blood transfusions, and the mean surgical time was 183 ± 42 minutes. Postoperatively, the mean visual analog scale pain score on postoperative day 1 was 4 ± 2 (range, 0-7), and the mean length of stay was 3.3 days. Postoperative complications included urinary tract infections in 2 patients, urinary retention in 2 patients, and recurrence of paroxysmal atrial fibrillation in 1 patient. No patient was readmitted within 90 days of surgery. One patient underwent a reoperation 2 years postoperatively for symptomatic hardware removal (cerclage cables around the tuberosities). A matched cohort of staged bilateral total shoulder arthroplasty patients was analyzed for comparison. Postoperative complications in the staged group included 1 reverse total shoulder arthroplasty patient with subjective instability that was managed with additional physical therapy. There were no documented readmissions within 90 days or revision arthroplasty procedures in either cohort. CONCLUSIONS: SBSA is a reasonable procedure that can be useful in select patients, with promising short-term safety noted in this series. Prospective randomized studies are needed to assess the long-term safety and efficacy of the procedure.

Stemless reverse total shoulder arthroplasty: a systematic review.

BACKGROUND: The use of reverse total shoulder arthroplasty and stemless anatomic total shoulder replacement has been increasing in the United States every year. Stemless humeral components in reverse total shoulder arthroplasty are only approved for clinical trials in the United States with an investigational device exception with limited data. METHODS: A systematic review on stemless reverse total shoulder arthroplasty was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. A search was conducted on November 25, 2020, using the MEDLINE/PubMed, Cochrane, and Embase databases. All articles were reviewed by 2 independent evaluators, with any conflicts or issues resolved by consensus or a final decision by the senior author. The primary outcomes extracted were complications, radiographic results, and outcome scores. RESULTS: We evaluated 10 studies that used either the Total Evolutive Shoulder System (TESS) or Verso implant. There were 430 total patients and 437 total procedures; 266 patients in the TESS group underwent a total of 272 procedures, and 164 patients in the Verso group underwent a total of 165 procedures. The mean age at the time of surgery was 73.8 years (range, 38-93 years). The mean follow-up period ranged from 6.4 to 101.6 months per study. There was an overall trend of improved clinical outcome scores, a 0.2% humeral component loosening rate, and an 11.2% complication rate. CONCLUSIONS: This review shows that the clinical and functional outcomes following stemless or metaphyseal reverse total shoulder arthroplasty are quite promising, especially with the low rate of humeral-sided complications. There continues to be a need for additional long-term studies and randomized clinical trials.

Emerging Applications of Stem Cell and Regenerative Medicine to Sports Injuries.

BACKGROUND: The treatment of sports-related musculoskeletal injuries with stem cells has become more publicized because of recent reports of high-profile athletes undergoing stem cell procedures. There has been increased interest in defining the parameters of safety and efficacy and the indications for potential use of stem cells in clinical practice. PURPOSE: To review the role of regenerative medicine in the treatment of sports-related injuries. STUDY DESIGN: Review. METHOD: Relevant studies were identified through a PubMed search combining the terms stem cells and cartilage, ligament, tendon, muscle, and bone from January 2000 to August 2013. Studies and works cited in these studies were also reviewed. RESULTS: Treatment of sports-related injuries with stem cells shows potential for clinical efficacy from the data available from basic science and animal studies. CONCLUSION: Cell-based therapies and regenerative medicine offer safe and potentially efficacious treatment for sports-related musculoskeletal injuries. Basic science and preclinical studies that support the possibility of enhanced recovery from sports injuries using cell-based therapies are accumulating; however, more clinical evidence is necessary to define the indications and parameters for their use. Accordingly, exposing patients to cell-based therapies could confer an unacceptable risk profile with minimal or no benefit. Continued clinical testing with animal models and clinical trials is necessary to determine the relative risks and benefits as well as the indications and methodology of treatment.

What effect does anterior cruciate ligament tibial guide orientation have on tibial tunnel length?

PURPOSE: To evaluate the effects of alteration in tibial guide pin insertion angle and external starting point on tibial tunnel length for anterior cruciate ligament (ACL) reconstruction. METHODS: Ten cadaveric tibial specimens were used. One pin was placed at each of variable insertion angles (55°, 50°, and 45°) of the tibial targeting device aimed at the center of the tibial ACL footprint. These 3 pins started externally along the anterior border of the superficial medial collateral ligament. A fourth pin at 50° was placed at a different external tibial starting point 1.5 cm anterior to the anterior border of the superficial medial collateral ligament. The intraosseous length of each pin was measured. Statistic analyses were performed with the Kruskal-Wallis test, with significance set at P < .05. RESULTS: The mean length for the 55° tibial tunnel was 50.3 mm (range, 42 to 56 mm); for the 50° tunnel, it was 48.9 mm (range, 44 to 55 mm); for the 50° anterior tunnel, it was 47.6 mm (range, 39 to 55 mm); and for the 45° tunnel, it was 47.3 mm (range, 41 to 52 mm). Changing the angle of the tibial guide did not significantly affect the length of the tibial tunnel (P = .18). Changing the external tibial starting point did not affect the length of the tibial tunnel (P = .39). CONCLUSIONS: Changing the tibial guide angle between 45°, 50°, and 55° does not appreciably change tibial tunnel length. Moving the starting point anterior 1.5 cm toward the tibial tubercle also has no effect on the tibial tunnel length. The lack of significant changes in tunnel length with these interventions may reflect the associated changes that occur in proximal tibial morphometry with change in external tibial starting position. CLINICAL RELEVANCE: Changing tibial tunnel length in ACL reconstruction likely requires more distalization of the external tibial starting point than is achieved simply by altering the tibial aiming guide angle by 10° or less.

Computed tomography as a predictor of hip stability status in posterior wall fractures of the acetabulum.

OBJECTIVES: Studies using 2-dimensional computed tomography-derived criteria indicate that, in general, posterior wall fractures involving less than 20% of the posterior wall are stable and able to withstand physiologic loads, whereas those involving greater than 40%-50% are unstable, leaving a wide range of posterior wall fractures classified as indeterminate. The purpose of this study was to assess the ability of static measurement of posterior acetabular wall fragment size using computed tomography to predict hip stability status, as determined by dynamic stress examination under anesthesia. DESIGN: Diagnostic level I. Retrospective analysis with testing of previously developed diagnostic criteria in a series of consecutive patients (with universally applied reference "gold" standard). SETTING: Level I trauma center. PATIENTS: Thirty-three consecutive patients with isolated unilateral posterior wall (OTA 62-A1) acetabular fractures were evaluated by dynamic fluoroscopic stress testing under general anesthesia (examination under anesthesia) to determine hip stability status and subsequent clinical treatment. INTERVENTION: Three methods were used in a blinded fashion to calculate posterior wall fracture fragment size using 2-dimensional computed tomograms. These methods include those previously described by Calkins et al, which measures the smallest amount of intact acetabular arc, and Keith et al, which measures fragment size at the level of the fovea, and an alternative modification of that of Keith et al using the level of largest posterior wall deficit. Each method classifies hip instability into 3 groups: (1) stable, (2) indeterminate, and (3) unstable. The examination under anesthesia served as the gold standard. MAIN OUTCOME MEASUREMENT: Examination under anesthesia RESULTS: Examination under anesthesia determined 15 hips to be unstable and 18 hips to be stable. The analyses showed that the methods of Calkins et al and Keith et al had a substantial percentage of incorrect predictions, especially in the critical group 1 patients (those predicted to be stable but were actually unstable). The percent incorrectly predicted for these group 1 patients was 33.3% (positive predictive value 66.7%) for the data derived form Calkins et al and 14.3% (positive predictive value 85.7%) for the data derived form Keith et al. In contradistinction, for the alternative method, specificity, sensitivity, and positive predictive value were all 100% with a 0% incorrectly predicted. However, with this alternative method, there was an increase in the number of group 2 fractures (23), as compared with the group 2 numbers for Calkins et al (n = 7) and Keith et al (n = 18). Reanalysis of the data for better potential cut points indicated that none of the methods could be improved in this way. CONCLUSIONS: The alternative method is the only reliable technique that is predictive of hip stability for small fracture fragments while also being predictive of instability for large fracture fragments. However, these findings are based on small patient numbers, and there remain a substantial number of fractures involving 20% or more of the posterior wall that are both stable and unstable by examination under anesthesia. Therefore, given the low risk of the stress examination and the inherent problems making the computed tomography measurements, dynamic fluoroscopic stress testing under general anesthesia should be the preferred method for the determination of hip stability status after posterior wall fractures of the acetabulum.